Masanori Isaka

980 total citations
48 papers, 826 citations indexed

About

Masanori Isaka is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Masanori Isaka has authored 48 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 25 papers in Public Health, Environmental and Occupational Health and 13 papers in Epidemiology. Recurrent topics in Masanori Isaka's work include Antimicrobial Resistance in Staphylococcus (25 papers), Streptococcal Infections and Treatments (25 papers) and Immune Response and Inflammation (9 papers). Masanori Isaka is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (25 papers), Streptococcal Infections and Treatments (25 papers) and Immune Response and Inflammation (9 papers). Masanori Isaka collaborates with scholars based in Japan, United States and China. Masanori Isaka's co-authors include Tadao Hasegawa, Ichiro Tatsuno, Yoko Yasuda, Kunio Tochikubo, Keiko Matano, Tooru Taniguchi, Masaaki Minami, Satoshi Kozuka, Jun‐ichi Maeyama and Kunio Ohkuma and has published in prestigious journals such as PLoS ONE, FEBS Letters and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Masanori Isaka

47 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masanori Isaka Japan	18	380	299	237	204	151	48	826
Adeline R. Porter United States	15	341 0.9×	221 0.7×	210 0.9×	212 1.0×	315 2.1×	27	1.1k
J L Michel United States	17	292 0.8×	660 2.2×	153 0.6×	394 1.9×	162 1.1×	20	1.0k
Petra L. Kohler United States	11	381 1.0×	106 0.4×	154 0.6×	112 0.5×	324 2.1×	14	789
Scilla Buccato Italy	11	280 0.7×	453 1.5×	120 0.5×	246 1.2×	394 2.6×	13	856
Guadalupe Cortés Spain	9	127 0.3×	106 0.4×	168 0.7×	174 0.9×	151 1.0×	10	646
Rebecca J. Smith United Kingdom	12	535 1.4×	142 0.5×	110 0.5×	437 2.1×	266 1.8×	15	880
Pierre Kyme United States	14	247 0.7×	152 0.5×	172 0.7×	142 0.7×	250 1.7×	17	893
Izabela Sitkiewicz Poland	21	585 1.5×	803 2.7×	70 0.3×	331 1.6×	344 2.3×	53	1.4k
Adam R. Spaulding United States	11	600 1.6×	134 0.4×	217 0.9×	227 1.1×	338 2.2×	12	941
Runying Tian United States	3	214 0.6×	388 1.3×	130 0.5×	250 1.2×	478 3.2×	5	1.1k

Countries citing papers authored by Masanori Isaka

Since Specialization

Citations

This map shows the geographic impact of Masanori Isaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masanori Isaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masanori Isaka more than expected).

Fields of papers citing papers by Masanori Isaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masanori Isaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masanori Isaka. The network helps show where Masanori Isaka may publish in the future.

Co-authorship network of co-authors of Masanori Isaka

This figure shows the co-authorship network connecting the top 25 collaborators of Masanori Isaka. A scholar is included among the top collaborators of Masanori Isaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masanori Isaka. Masanori Isaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tatsuno, Ichiro, et al.. (2018). Functional Predominance of msr (D), Which Is More Effective as mef( A)-Associated Than mef( E)-Associated, Over mef (A)/ mef (E) in Macrolide Resistance in Streptococcus pyogenes. Microbial Drug Resistance. 24(8). 1089–1097. 19 indexed citations

Hasegawa, Tadao, et al.. (2017). Characterisation of clinically isolated Streptococcus pyogenes from balanoposthitis patients, with special emphasis on emm89 isolates. Journal of Medical Microbiology. 66(4). 511–516. 6 indexed citations

Nishio, Naomi, Tadao Hasegawa, Ichiro Tatsuno, Masanori Isaka, & Ken‐ichi Isobe. (2017). Female GADD34 mice develop age‐related inflammation and hepatocellular carcinoma. Geriatrics and gerontology international. 17(12). 2593–2601. 5 indexed citations

Zhang, Yan, Ichiro Tatsuno, Ryo Okada, et al.. (2015). Predominant role of msr(D) over mef(A) in macrolide resistance in Streptococcus pyogenes. Microbiology. 162(1). 46–52. 32 indexed citations

Okada, Ryo, Masakado Matsumoto, Yan Zhang, et al.. (2014). Emergence of type I restriction modification system‐negative emm1 type Streptococcus pyogenes clinical isolates in Japan. Apmis. 122(10). 914–921. 13 indexed citations

Maeyama, Jun‐ichi, Hisakazu Takatsuka, Fumiko Suzuki, et al.. (2014). A Palindromic CpG-Containing Phosphodiester Oligodeoxynucleotide as a Mucosal Adjuvant Stimulates Plasmacytoid Dendritic Cell-Mediated TH1 Immunity. PLoS ONE. 9(2). e88846–e88846. 16 indexed citations

Okada, Ryo, Yan Zhang, Masanori Isaka, et al.. (2014). Simultaneous isolation of emm89-type Streptococcus pyogenes strains with a wild-type or mutated covS gene from a single streptococcal toxic shock syndrome patient. Journal of Medical Microbiology. 63(4). 504–507. 14 indexed citations

Tatsuno, Ichiro, Masanori Isaka, Ryo Okada, Yan Zhang, & Tadao Hasegawa. (2014). Relevance of the two-component sensor protein CiaH to acid and oxidative stress responses in Streptococcus pyogenes. BMC Research Notes. 7(1). 189–189. 25 indexed citations

Tatsuno, Ichiro, Ryo Okada, Yan Zhang, Masanori Isaka, & Tadao Hasegawa. (2013). Partial loss of CovS function in Streptococcus pyogenes causes severe invasive disease. BMC Research Notes. 6(1). 126–126. 30 indexed citations

10.

Minami, Masaaki, Masakado Matsumoto, Yasue Kubota, et al.. (2010). Characterization of Streptococcus pyogenes Isolated from Balanoposthitis Patients Presumably Transmitted by Penile-Oral Sexual Intercourse. Current Microbiology. 61(2). 101–105. 11 indexed citations

11.

Hasegawa, Tadao, Akira Okamoto, Ichiro Tatsuno, et al.. (2010). Detection of invasive protein profile of Streptococcus pyogenes M1 isolates from pharyngitis patients. Apmis. 118(3). 167–178. 25 indexed citations

12.

Minami, Masaaki, Ichiro Tatsuno, Masanori Isaka, et al.. (2009). The streptococcal inhibitor of complement (SIC) protectsStreptococcus pyogenesâ from bacteriocin-like inhibitory substance (BLIS) fromStreptococcus salivarius. FEMS Microbiology Letters. 298(1). 67–73. 7 indexed citations

13.

Isaka, Masanori, Yanqiu Zhao, Eri Nobusawa, et al.. (2008). Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice. Microbiology and Immunology. 52(2). 55–63. 18 indexed citations

14.

Maeyama, Jun‐ichi, Masanori Isaka, Yoko Yasuda, et al.. (2004). Effects of Recombinant Cholera Toxin B Subunit (rCTB) on Cellular Immune Responses: Enhancement of Delayed‐Type Hypersensitivity Following Intranasal Co‐Administration of Mycobacterium bovis‐BCG with rCTB. Microbiology and Immunology. 48(6). 457–463. 8 indexed citations

15.

Isaka, Masanori, Takako Komiya, Motohide Takahashi, et al.. (2004). Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria–pertussis–tetanus (DPT) combination vaccine. Vaccine. 22(23-24). 3061–3068. 20 indexed citations

16.

Isaka, Masanori, Yoko Yasuda, Masashi Mizokami, et al.. (2001). Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant. Vaccine. 19(11-12). 1460–1466. 69 indexed citations

17.

Goto, Norihisa, Jun‐ichi Maeyama, Yoko Yasuda, et al.. (2000). Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant. Vaccine. 18(20). 2164–2171. 34 indexed citations

18.

Isaka, Masanori, Yoko Yasuda, Satoshi Kozuka, et al.. (1999). Intranasal or subcutaneous co-administration of recombinant cholera toxin B subunit stimulates only a slight or no level of the specific IgE response in mice to tetanus toxoid. Vaccine. 17(7-8). 944–948. 9 indexed citations

19.

Tochikubo, Kunio, Masanori Isaka, Yoko Yasuda, et al.. (1998). Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin. Vaccine. 16(2-3). 150–155. 71 indexed citations

20.

Motojima, Kiyoto, et al.. (1994). Transient induction of fatty acid synthase in rat liver after removal of a peroxisome proliferator. FEBS Letters. 356(1). 122–124. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact